Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Severe Asthma Questionnaire (SAQ) is sensitive to change and clinically significant improvement was detected within 4 weeks of starting biologic therapy. The MCID of the SAQ is 0.5 and of the SAQ-global is 11. https://bit.ly/3poJqcG

More information Original publication

DOI

10.1183/13993003.00300-2021

Type

Journal article

Publication Date

2021-06-01T00:00:00+00:00

Volume

57

Keywords

Asthma, Humans, Minimal Clinically Important Difference, Surveys and Questionnaires